Is There A Business Case For Health IT Regulation? - Opposing Viewpoints
This article was originally published in The Gray Sheet
Executive Summary
Health IT software developers may be keen to avoid FDA oversight of their products, but some experts say regulation may actually provide market benefits
You may also be interested in...
Mobile Health Device Field Seeks Regulatory Guidance From FDA And FCC
Even as the use of mobile wireless devices for medical applications burgeons, some would-be entrepreneurs and venture capitalists are holding back from entering the field until they get a better handle on the regulatory hurdles involved
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.